New perspectives on effector mechanisms in uveitis
- PMID: 18317764
- PMCID: PMC2756230
- DOI: 10.1007/s00281-008-0108-5
New perspectives on effector mechanisms in uveitis
Abstract
Experimental autoimmune uveitis (EAU) in its several variants represents human autoimmune uveitis and has been instrumental in obtaining insights into the basic mechanisms of disease. Studies have uncovered that in addition to CD4+ Th1 cells, uveitis can be induced also by CD8+ T cells. Antibodies may have a secondary role after the blood-retinal barrier has been broken. The role in uveitis of a recently discovered IL-17-producing effector T cell type, Th17, is being intensively studied. Th17 cells elicit EAU, can be found in uveitic eyes along with Th1 cells, and are dominant in some types of EAU. In other types of EAU, Th1 cells have a dominant role. The dominant effector type is at least in part determined by conditions under which initial exposure to self-antigen occurs. These findings shed light on the heterogeneity of human disease and may ultimately help to develop better and more rational treatment strategies for human uveitis.
Figures



Similar articles
-
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.J Exp Med. 2008 Apr 14;205(4):799-810. doi: 10.1084/jem.20071258. Epub 2008 Apr 7. J Exp Med. 2008. PMID: 18391061 Free PMC article.
-
Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.Int J Mol Sci. 2021 Jul 14;22(14):7517. doi: 10.3390/ijms22147517. Int J Mol Sci. 2021. PMID: 34299138 Free PMC article.
-
Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype.J Immunol. 2007 May 1;178(9):5578-87. doi: 10.4049/jimmunol.178.9.5578. J Immunol. 2007. PMID: 17442940
-
Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells.Immunol Res. 2008;42(1-3):41-50. doi: 10.1007/s12026-008-8031-3. Immunol Res. 2008. PMID: 18629448 Free PMC article. Review.
-
[Translational research with experimental autoimmune uveoretinitis (EAU)].Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):137-58; discussion 159. Nippon Ganka Gakkai Zasshi. 2007. PMID: 17402560 Review. Japanese.
Cited by
-
Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis.Cytokine. 2013 Mar;61(3):862-75. doi: 10.1016/j.cyto.2013.01.009. Epub 2013 Feb 14. Cytokine. 2013. PMID: 23415673 Free PMC article.
-
Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.Invest Ophthalmol Vis Sci. 2011 Oct 11;52(11):8033-41. doi: 10.1167/iovs.11-7485. Invest Ophthalmol Vis Sci. 2011. PMID: 21900376 Free PMC article.
-
Autoimmune uveitis attenuated in diabetic mice through imbalance of Th1/Th17 differentiation via suppression of AP-1 signaling pathway in Th cells.Front Immunol. 2024 Jun 3;15:1347018. doi: 10.3389/fimmu.2024.1347018. eCollection 2024. Front Immunol. 2024. PMID: 38887289 Free PMC article.
-
Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells.Front Immunol. 2018 Jul 9;9:1567. doi: 10.3389/fimmu.2018.01567. eCollection 2018. Front Immunol. 2018. PMID: 30050530 Free PMC article.
-
Cytokines in autoimmune uveitis.J Interferon Cytokine Res. 2011 Oct;31(10):733-44. doi: 10.1089/jir.2011.0042. Epub 2011 Jul 25. J Interferon Cytokine Res. 2011. PMID: 21787221 Free PMC article. Review.
References
-
- Agarwal RK, Caspi RR. Rodent models of experimental autoimmune uveitis. Methods Mol Med. 2004;102:395–420. - PubMed
-
- Tang J, Zhu W, Silver PB, Su SB, Chan CC, Caspi RR. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol. 2007;178:5578–5587. - PubMed
-
- Nussenblatt RB. Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int Rev Immunol. 2002;21:273–289. - PubMed
-
- Caspi RR, Silver PB, Chan CC, Sun B, Agarwal RK, Wells J, Oddo S, Fujino Y, Najafian F, Wilder RL. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol. 1996;157:2668–2675. - PubMed
-
- Caspi RR. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int Rev Immunol. 2002;21:197–208. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials